Review of clinical studies on clobazam

Br J Clin Pharmacol. 1979;7 Suppl 1(Suppl 1):139S-150S. doi: 10.1111/j.1365-2125.1979.tb04684.x.

Abstract

1 Clobazam was compared with placebo and diazepam in 45 double-blind studies. 2 Clobazam dosage ranged from 5 mg daily (paediatric patients) to 120 mg daily (psychiatric in-patients). Usual daily dosage in out-patient therapy ranged from 20-30 mg clobazam. 3 Treatment duration varied from a few days up to 3.5 years. The usual duration of treatment was 2-4 weeks. 4 Clobazam was shown to be an efficacious and well tolerated anxiolytic agent in various neurotic and psychosomatic disorders. 5 Dosages showing distinct anxiolytic effects in out-patient therapy did not impair psychomotor performance.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Alcoholism / drug therapy
  • Anti-Anxiety Agents / adverse effects
  • Anti-Anxiety Agents / therapeutic use*
  • Anxiety / drug therapy
  • Anxiety Disorders / drug therapy
  • Child
  • Clinical Trials as Topic
  • Diazepam / adverse effects
  • Diazepam / therapeutic use
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Motor Skills / drug effects
  • Psychophysiologic Disorders / drug therapy
  • Psychotic Disorders / drug therapy
  • Sleep Wake Disorders / drug therapy
  • Substance Withdrawal Syndrome / drug therapy
  • Time Factors

Substances

  • Anti-Anxiety Agents
  • Diazepam